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We found an epidemiological association of Hafnia alvei with diarrhea, because the organism was isolated
from 12 of 77 (16%) adult Finnish tourists to Morocco who developed diarrhea and from 0 of 321 tourists
without diarrhea (P < 0.001). From another group of 112 adult Finnish diarrheal patients, only 2 (2%) yielded
H. alvei. In contrast to some Bangladeshi strains of H. alvei, the Finnish strains were negative for the
attachment-effacement lesion by an in vitro fluorescent actin staining test and also did not show homology to
the Escherichia coli attachment-effacement gene (eaeA) by PCR. These results suggest that a mechanism or
mechanisms other than the attachment-effacement lesion may also be involved in the association of H. alvei
with diarrhea.
Recently, Hafnia alvei strains isolated from diarrheal feces
of Bangladeshi children have been reported to cause attaching-
effacing (AE) lesions typical of enteropathogenic Escherichia
coli (EPEC) (2, 5). These strains also hybridized with the
EPEC eaeA probe. The eaeA gene is the only virulence-
associated factor described so far for H. alvei. Genes belonging
to the eaeA gene cluster are reported to occur also in entero-
hemorrhagic E. coli and in one biotype of Citrobacter freundii
(9). The aim of the present study was to clarify the potential
role of H. alvei as an enteropathogen. We determined the
isolation rate of H. alvei in subjects with and without diarrheal
symptoms and screened the isolates for the ability to produce
the AE lesion and for the possession of the eaeA gene.
Fecal samples were obtained from three groups of adult
Finnish people (510 people in all). Diarrhea group 1 consisted
of 77 travelers examined during or immediately after travel to
Morocco between January and February 1989. Diarrhea group
2 consisted of 112 patients examined between March and June
1993 as a routine diagnostic measure when they consulted a
physician because of diarrhea symptoms. Of these patients, 71
had recently traveled abroad, mostly to the Mediterranean or
Far Eastern countries. The third group formed a control group
of 321 nondiarrheal travelers examined immediately after their
return from Morocco in 1989. All stool samples were cultured
by standard methods and studied for Salmonella, Shigella,
Campylobacter, Yersinia, Aeromonas, and Plesiomonas species
as described previously (6). The specimens of diarrhea group 1
and the control group were also processed for different types of
diarrheagenic E. coli, rotaviruses and adenoviruses, and intes-
tinal parasites (8). In diarrhea group 1 and the control group,
one to three colonies were subcultured from primary nonse-
lective Drigalski-Conradi agar for species identification with
the API 20 E system (BioMerieux, Marcy l'Etoile, France). In
diarrhea group 2, the cultures on nonselective cystine-lactose-
electrolyte-deficient agar were screened for the presence of H.
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alvei: 5 to 10 colonies were tested for the hydrolysis of
L-proline-p-nitroanilide for detecting H. alvei (3). The final
species identification was performed with the API 20 E system.
Statistical analysis was done with the x2 test.
The study also included six H. alvei strains isolated from
diarrheal patients in Bangladesh and previously reported to
produce AE lesions (strains 10457, 10790, 19982, 38/90, 9194,
and 12502 [2]). Strains 10790 and 19982 were also reported to
hybridize with the EPEC E2348/69-specific eaeA probe. EPEC
E2348/69 (127:H6) obtained from J. P. Nataro (Center for
Vaccine Development, University of Maryland, School of
Medicine, Baltimore) was used as a positive control when
searching for the eaeA gene. In addition, H. alvei ATCC 13337
(type strain) and ATCC 29927 (DNA reference strain) were
included. The ability to produce the AE lesion was screened by
the fluorescent actin staining test with HEp-2 cells (2). Posses-
sion of the eaeA gene was tested by PCR. For this determina-
tion, bacterial strains were grown in brain heart infusion broth
(Difco, Detroit, Mich.) overnight at 37°C. Each sample was
prepared by boiling 100 ,ul of a 10-3 dilution of bacterial
culture (final bacterial concentration, 106/ml) with 100 ,ul of
2% Triton X-100 for 10 min. Primers (sense, 5'GATCTCT
GAACGGCGATTACGCG3'; antisense, 5'CTTCGGTGCCA
TCCGCT'1T'AGCC3') were derived from the conserved re-
gion (residues 2182 to 3372) of the EPEC E2348/69 (GenBank
accession numbers M58154 and M34051) eaeA gene. Amplifi-
cations were performed with a DNA thermal cycler (PTC-100;
MJ Research, Watertown, Mass.) for 35 cycles of 30 s at 95°C,
30 s at 62°C, and 2 min at 72°C with 3 min of initial
denaturation at 95°C and 5 min of final extension at 72°C in a
25-,ul volume containing 5 pul of sample and 1 U of Dynazyme
DNA polymerase (Finnzymes, Espoo, Finland) in a buffer
provided by the manufacturer and overlaid with 30 ,ul of sterile
paraffin oil. Negative (Serratia liquefaciens) and positive
(EPEC E2348/69) controls were included with each experi-
ment. The amplification product generated in the PCR assay
with H. alvei reference strain 10457 was cloned into SmaI-
digested Bluescript KS vector (Stratagene, La Jolla, Calif.).
Two plasmids containing the insert were sequenced by the
dideoxy method with the AutoRead kit (Pharmacia, Uppsala,
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TABLE 1. Isolation of H. alvei from stool samples of diarrheal
and nondiarrheal subjects
No. (%) of H. alvei-positive
stool samples from:
Group Diarrheal patients Nondiarrheal
Group la Group 2b subjectsa
(n = 77) (n = 112) (n = 321)
All subjects with H. alvei 12 (16)C 2 (2) 0
Subjects with H. alvei alone 4 (5) 2 (2) 0
Subjects with H. alvei 8 (10)d 0 0
together with other
enteropathogen(s)
Subjects with known 48 (62)e 12 (11)' 34 (11)e
enteropathogens
a Finnish travelers to Morocco in 1989 with or without diarrhea (partly
described previously [6]).
b Finnish patients examined in 1993 by a general practitioner because of
diarrheal symptoms.
'P < 0.001 versus diarrhea group 2 and nondiarrheal subjects.
d C. jejuni, five patients; Aeromonas spp., three patients.
eSee reference 6.
f Salmonella enterica, six patients; C. jejuni, four patients; Aeromonas spp., two
patients; Shigella sonnei, one patient. In one sample, two pathogens were
isolated.
Sweden) and analyzed with an automated laser fluorescent
DNA sequencer (Pharmacia, Uppsala, Sweden). The se-
quences were aligned by the Bestfit program (Genetics Com-
puter Group package, University of Wisconsin, Madison).
Among 398 travelers to Morocco, 12 of 77 (16%) with
diarrhea had H. alvei in their stool samples in contrast to 0 of
321 without diarrhea (P < 0.001) (Table 1). The total number
of H. alvei isolates recovered was 24 (1 to 3 from each of 12
patients). In diarrhea group 2, only 2 of 112 subjects (2%) had
H. alvei in their stool samples; in these 2 specimens, a total of
15 isolates studied were H. alvei. One subject had recently
visited Sweden, and the other did not travel abroad. H. alvei
was significantly more common (P < 0.001) in diarrhea group
1 than in group 2. Other enteropathogens together with H.
alvei were isolated from stool specimens of eight patients in
diarrhea group 1 (tourists who visited Morocco); these in-
cluded five patients with Campylobacter jejuni and three with
Aeromonas spp. Thus, H. alvei was the only putative pathogen
in four (5%) of the tourists with diarrhea (Table 1). The
recognized pathogens isolated from stool samples of diarrhea
group 1 and the control group have been published (6). In
diarrhea group 2, stool specimens of 12 patients (11%) con-
tained known enteropathogens (Table 1). In this group, nei-
ther of the two specimens with H. alvei contained recognized
enteropathogens. All 47 H. alvei isolates (39 from Finnish
patients, 6 from Bangladesh, and 2 American Type Culture
Collection strains) were tested for AE lesions by the fluores-
cent actin staining test and for the eaeA gene by PCR assay
with EPEC-specific (E2348/69) primers. All isolates from
Finnish patients and the American Type Culture Collection
strains were negative in both tests, whereas all Bangladeshi
strains reacted positively in the fluorescent actin staining test
and generated a product of the predicted size (Fig. 1). The
1,191-bp fragment generated in the PCR assay with strain
10457 was sequenced. The sequence obtained showed about
90% homology with other published eaeA gene sequences
(result not shown).
The previous studies of the role of H. alvei in causing
diarrhea were concerned only with case reports (1, 7, 8, 11).
Ours is the first controlled study which suggests an epidemio-
1191 bp -a
FIG. 1. PCR assay to detect the eaeA gene in H. alvei strains.
Lanes: 1, molecular weight marker (Lambda DNA BsteII digest); 2,
EPEC E2348/69 (positive control); 3, S. liquefaciens (negative control);
4 to 6, H. alvei 10457, 10790, and 1982, respectively; 7 and 8, H. alvei
ATCC 13337 and 29927, respectively; 9 to 12, H. alvei IH 50978, IH
51199, IH 51030, and IH 51323, respectively, isolated from study group
1; 13 and 14, H. alvei IH 53200 and IH 53201, respectively, isolated
from study group 2. Note that a PCR product of 1,191 bp is generated
by isolates from Bangladesh only.
logical association with diarrhea for this organism. It can be
argued that H. alvei cells are transient organisms; if so, they
should also have been isolated from controls without diarrhea.
Since controls did not yield this organisms, this possibility is
unlikely. In positive specimens, we have found 2 to 10 colonies
of H. alvei, and this organism was found significantly more
frequently in patients with diarrhea acquired in Morocco than
in diarrheal patients in Finland. It may be that H. alvei is more
prevalent in Morocco than in Finland.
The present study confirmed that some Bangladeshi H. alvei
strains previously reported to be positive for gene sequences
homologous to eaeA were indeed so (2). However, strains
isolated from Finnish subjects did not contain such a gene
sequence. The absence of the eaeA gene sequence was further
confirmed by a negative fluorescent actin staining test. It is
possible that these strains may possess other virulence factors
for production of diarrhea. The demonstration of such viru-
lence factors and other case-control studies are needed to
further argue for a role for H. alvei in causing diarrhea. In
addition, the taxonomy of this species needs to be studied more
closely. According to DNA-relatedness studies, biochemically
defined species of H. alvei may consist of several genospecies
(4, 10).
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